Rhenman & Partners Asset Management AB
Position in NBIX — Neurocrine Biosciences Inc
CIK 1599882
Stockholm, V7
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,467,642
+$1,182,849 QoQ
Shares Held
85,841
-14.9% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#130
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $24,174,742 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (59.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
85,841 | $14,467,642 | |
| 2 | ALKS |
Alkermes plc.
|
185,250 | $9,707,100 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,467,642 | 85,841 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $13,284,793 | 100,841 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $17,798,388 | 125,491 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,103,972 | 114,717 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $18,755,084 | 149,217 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,933,760 | 89,817 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,693,270 | 100,317 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,267,035 | 71,750 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,401,656 | 75,555 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,137,280 | 59,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,169,120 | 62,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,138,675 | 54,566 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,772,000 | 40,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,085,400 | 70,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,152,400 | 85,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,815,430 | 83,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,260,600 | 95,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,843,750 | 105,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $12,869,187 | 151,100 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,111,450 | 95,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $10,218,600 | 105,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $15,073,750 | 155,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $14,377,500 | 150,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $7,212,000 | 75,000 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $9,150,000 | 75,000 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $11,251,500 | 130,000 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||